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Vitamin K-dependent carboxylase, purified from bo- 
vine  liver, has properties similar to those reported for 
the carboxylase activity present in crude, solubilized 
microsomes. The purified carboxylase was found to 
possess the vitamin K epoxidase activity,  believed to 
be essential for vitamin K-dependent carboxylation, 
but did not contain vitamin K epoxide reductase activ- 
ity. Kinetic studies of the carboxylase done under de- 
fined conditions were complicated by the non-Michae- 
lis-Menten kinetic behavior observed for reactions 
with two of the enzymes substrates, FLEEL and vita- 
min K1 hydroquinone. Initial rate experiments with 
the substrate FLEEL demonstrated behavior consist- 
ent with substrate inhibition and gave half-maximal 
activity at 1 mM FLEEL. Experiments with the sub- 
strate vitamin K1 hydroquinone also displayed non- 
Michaelis-Menten kinetics, as maximal activity was 
reached prematurely in relation to behavior at lower 
concentrations. Half-maximal activity  was observed at 
35 PM vitamin K1 hydroquinone. Initial rate experi- 
ments with  varying NaH1*COs concentration displayed 
Michaelis-Menten kinetics and gave a of 0.29 
mM.  At cosubstrate concentrations chosen to obtain 
near-maximal activity,  initial  rate studies with  vary- 
ing NaHl4CO9 concentration indicated a kcat near 1.0 
s-’. Removal of the fourth substrate, oxygen, resulted 
in the loss of  more than 99% of carboxylase activity. 
The sulfhydryl reagent N-ethylmaleimide inhibited 
carboxylase irreversibly, as did the anticoagulant war- 
farin. 
The vitamin K-dependent carboxylase catalyzes the post- 
translational conversion of certain  glutamate residues to y- 
carboxyglutamate (Gla)’ residues, in a family of proteins that 
includes many blood-clotting factors. In the presence of Ca2+, 
these Gla residues confer functionally essential, membrane- 
binding capabilities upon the blood-clotting proteins. Since 
the discovery of Gla residues in prothrombin (1-3), the car- 
boxylase activity has been heavily studied, and many reviews 
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acid vitamin KHz, vitamin K1 hydroquinone; vitamin K epoxide, 
phylloquinone-2,3-oxide; NEM, N-ethylmaleimide; DTT, dithiothre- 
itol. 
are available (4-8). In addition to vitamin K hydroquinone 
and a carboxylatable substrate, the carboxylation reaction 
requires COS and O2 as  substrates. The carboxylase activity 
has been associated with a vitamin K epoxidase activity, and 
the available data indicate carboxylation is coupled to epoxi- 
dation  (6). Most studies of the carboxylase activity have  used 
detergent-solubilized microsomes and  synthetic peptide sub- 
strates  and have measured the amount of l4CO2 incorporated 
into  the peptide. The millimolar K,,, concentrations of these 
peptides (9) are too high to be  physiologically relevant,  and  it 
has been shown that  the precursor forms of native substrates 
contain  a carboxylase-binding site that binds carboxylase with 
submicromolar affinity (10-12). In blood-clotting factors and 
bone Gla protein, this “propeptide” region is at  the amino 
terminus and is  removed by a peptidase following carboxyla- 
tion. Although the propeptide is believed to function primarily 
as  a “docking site” for the carboxylase, it may also serve as 
an allosteric effector, as it lowers the K,  of the peptide 
substrates somewhat (10, 11, 13). The carboxylase is an  inte- 
gral membrane protein that resides in the rough endoplasmic 
reticulum (14)  and that has recently been purified (15)  and 
cloned (16). The deduced amino acid sequence suggests two 
major domains, including an amino-terminal hydrophobic 
domain that contains three probable membrane-spanning 
regions and  a hydrophilic domain that shows  homology to a 
known epoxidase (16). 
In crude, solubilized microsomes, the carboxylase activity 
shows a pH optimum around 7.0 and a sensitivity to salt 
concentration (9,17). Stimulators of the activity include DTT 
(9, 18, 19), ammonium sulfate (20, 21), and divalent metal 
ions (5,22).  The sulfhydryl-reactive agents N-ethylmaleimide 
(23)  and p-hydroxymercuribenzoate (9, 18, 19) block carbox- 
ylase activity, indicating the probable presence of one or two 
(23)  essential  sulfhydryl(s). The vitamin K  antagonist war- 
farin also inhibits carboxylation (24). The activity of partially 
purified carboxylase, bound to Sepharose beads via an  anti- 
body/native substrate bridge,  shows a requirement for neutral 
phospholipid (25). 
Despite the large amount of work done on the vitamin K- 
dependent carboxylase, progress in understanding  the mech- 
anism  has been hampered by the lack of a purified carboxylase 
preparation. We have recently purified the vitamin K-de- 
pendent carboxylase t o  near homogeneity (15)  and report here 
an initial  characterization of this purified enzyme. The puri- 
fied carboxylase has essentially the same behavior as the 
carboxylase activity found in crude, soluble microsomal prep- 
arations in regard to kinetic constants, inhibition by N- 
ethylmaleimide and warfarin, and activation by ammonium 
sulfate. In addition, in the presence of saturating sodium 
bicarbonate, equimolar amounts of Gla and vitamin K epoxide 
were formed as is the case in  the crude systems (26).  These 
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results suggest the purified carboxylase contains all of the 
activities that  are normally part of the carboxylation  reaction 
and  that  the carboxylase is  functioning  in  an analogous man- 
ner  in  the soluble crude and purified  systems. 
MATERIALS AND  METHODS 
Chemicals-Vitamin Kl (phylloquinone) at 10 mg/ml  was obtained 
from Abbott Laboratories in the form of a colloidal suspension 
(Vitamin K1 Injection) that includes 7% polyoxylated fatty acid, 
3.75% hydrous dextrose, and 0.9% benzyl alcohol. Alternatively, 
vitamin Kl was obtained from Sigma (V-3501). NaH14C03 from Du 
Pont-New England Nuclear was 1 pCi/pl with a specific activity of 
54 mCi/mmol. Phosphatidylcholine, type X-E, from dried egg  yolk, 
CHAPS, 3-(a-acetonylbenzyl)-4-hydroxycoumarin (warfarin), glu- 
cose oxidase (G-6891), catalase  (C-30), and N-ethylmaleimide were 
from Sigma. The peptide FLEEL was from Bachem, and  the peptide 
proFIX19 (AVFLDHENANKILNRPKPY) was synthesized by Dr. 
F. Church (University of North Carolina, Chapel Hill). 
Purification of Bovine  Carboxylase-Carboxylase  was affinity-pu- 
rified as previously described (15), except that  the protease inhibitor 
mixture was excluded from the CHAPS wash gradient and  the elution 
gradient. In some purifications, the elution gradient was extended to 
1.5% CHAPS and 3 p~ proFIX19 while maintaining the same slope. 
The fractions of carboxylase used in  this study  contained 1.2-2.4 p~ 
proFIX19, 0.6-1.2% CHAPS, 0.1% PC, 25 mM MOPS  (pH, 7.4), 500 
mM NaCI, and 20% glycerol (v/v). Carboxylase was quantitated by 
densitometric scanning of Coomassie-stained gels using IgG as a 
standard. Molar concentrations of carboxylase were calculated using 
a mass of 88 kDa (16). 
Carboxylase  Assay-After all  additions, the solution for the  stand- 
ard reaction included 25 mM MOPS (pH 7.4), 300 mM NaCI, 0.8 M 
(NH&SOI, 0.216% phosphatidylcholine, 0.3-0.4% CHAPS, 10.2-10.4 
p M  proFIX19,3.3% glycerol (v/v), and 6 mM DTT. Unless otherwise 
indicated, substrate  concentrations were  0.57 f 0.09 mM NaH14C03, 
222 p M  vitamin KHz, and 3.6 mM FLEEL. At the time of the assay, 
purified carboxylase (stored at -70 "C) was thawed and placed on ice. 
Between 28 and 112 ng of carboxylase in a volume of 20 p1 was added 
to 95 pl of ice-cold solution containing most of the reaction compo- 
nents. Unless otherwise stated, the reaction was started by the 
addition of 10 pl of an ice-cold 1:l solution of NaH14C03 and  DTT- 
reduced vitamin KHz. The 1.7-ml polypropylene tubes, containing 
125 pl of total reaction volume, were sealed, vortex-mixed, and placed 
in  a 22 f 1 "C water bath. At the desired times, the reactions were 
stopped by the addition of  75 pl of 1 N NaOH. Within an hour, 160 
pl of stopped reaction was transferred to a minivial containing one 
small (<2-mm diameter) Boileezer chip (Fisher) and 1 ml of 5% 
trichloroacetic acid. Samples were boiled until about 200  pl of solution 
remained. After cooling, 3 ml of Safety-solve scintillation mixture 
(Research Products  International Inc.) was added, and  the incorpo- 
rated "C counted with 90% efficiency (27). Background values ob- 
tained in the absence of vitamin KHz or FLEEL were generally 
negligible (<200 cpm) if the Boileezer chips were presoaked for 1 h 
or more in the acid. Data points  are the average of two assay points 
done as duplicates unless otherwise stated. To estimate the actual 
NaH"C03 concentration, 10 pl of the stopped reaction was counted. 
Vitamin K1 (Abbott Laboratories) a t  10 mg/ml was reduced by 
addition to 3 volumes of buffer containing 200 mM DTT, 500 mM 
NaC1, and 20 mM Tris, pH 8.5 (28). Full tubes were incubated in 
darkness at 4 "C for at least 36 h to ensure complete reduction. 
Alternatively, 250  mg  of vitamin K1 (Sigma) dissolved in ether  at 10 
mg/ml  was  reduced  by shaking for 30 min in  a  separatory  funnel with 
2 volumes of 10% sodium hydrosulfite (29). All steps  in the reduction 
used nitrogen-equilibrated solutions and were done under nitrogen 
atmosphere. The aqueous phase was removed, and  the  ether phase 
was washed with 0.5 volume of water to prevent possible hydrosulfite 
inhibition of carboxylase (30). Ether was dried off under  a  stream of 
nitrogen, and  the vitamin KHz was resuspended in ethanol and stored 
under nitrogen at 12.5  mg/ml. Various concentrations of hydrosulfite- 
reduced vitamin KHz were obtained by dilution of this stock in 
nitrogen-equilibrated ethanol  under  a nitrogen atmosphere such that 
2 pl of each stock was added to a reaction. Hydrosulfite-reduced 
vitamin KHz in ethanol was added within 15 min of the reaction 
start, which  was initiated by the addition of 5 pl of NaHl4CO, and 
transfer to 22 "C. Reactions were done using standard conditions, 
including DTT unless otherwise indicated. 
Additions of vitamin K epoxide and vitamin K, were made from 
13.9 mM ethanolic stocks to  the reaction mixture within 15 min of 
the beginning of the assay. 
The substrate  FLEEL, which included 0.5  mol  of acetic acid/mol 
of peptide, was dissolved with a slight excess of equivalents of 1 N 
NaOH. Addition of MOPS (pH 7.4) and dilution with HzO yielded a 
125 mM FLEEL stock buffered with 16.6 mM MOPS at a  pH below 
8.0.  Lower concentration stocks were produced by dilution with 16.6 
mM MOPS (pH 7.4). 
Carboxylase Stability-To determine the stability of carboxylase 
fractions from the affinity purification, aliquots of fractions were 
frozen in liquid nitrogen and stored at -70 "C. At various times, they 
were thawed and incubated at  the appropriate  temperature for up to 
90 h, after which all samples were assayed together. Freeze-thawing 
three times and storage at -70  "C for up to 6  months do not  appre- 
ciably decrease activity. 
Vitamin K Epoxidase and Vitamin K Epoxide Reductase Actiui- 
ties-Purified carboxylase was flushed with 0, for several minutes 
and left under oxygen atmosphere overnight to remove as much 
endogenous NaHC03  as possible. To compare epoxidase and carbox- 
ylase activities, reactions were performed under otherwise standard 
conditions using 10 mM NaHC03 or NaH"C03, respectively. The 
vitamin K epoxide formed was extracted and quantitated as previ- 
ously described (31), except that addition of silver nitrate was omitted. 
Vitamin K epoxide reductase was assayed and quantitated in the 
same manner as  the epoxidase, except that vitamin KO  was  used as 
substrate in place of vitamin KHz. In cases where the amount of 
vitamin KHz was estimated, reactions were equilibrated with nitro- 
gen, extracted with nitrogen-equilibrated 2:3 hexane/isopropanol and 
subjected to high performance liquid chromatography with nitrogen- 
equilibrated solutions. 
Kinetic Studies-For initial rate experiments with varying Na- 
H"CO3 concentration, the carboxylation reactions were started by 
the addition of 35  pl of ice-cold mixture containing  5 p1 of vitamin 
KHz and variable amounts of NaH"COz and deionized water. As in 
the standard assay, NaHl4CO2 concentrations were determined by 
scintillation counting. For  initial  rate experiments with varied con- 
centrations of vitamin KHz, the vitamin KHz was diluted in buffer 
consisting of 15 mM Tris  (pH 8.5), 150 mM DTT,  and 375 mM NaCl, 
prior to combination with Na1*HCOZ and addition to  the reaction. 
Estimates of K, and Vmax, made using least squares regression on 
Lineweaver-Burk or Eadie-Hofstee plots or using nonlinear least 
squares regression with the Michaelis-Menten equation on Sigma 
Plot, gave essentially the same results. Regressions were unweighted. 
Experiments done under oxygen atmosphere used samples that 
were  twice flushed with oxygen and vortex-mixed prior to  the reaction 
start. Deoxygenation of reaction mixtures was accomplished by place- 
ment under a Nz atmosphere and inclusion of 0.1 mg/ml glucose 
oxygenase, 0.2 mg/ml catalase, 50 mM glucose, and 2% ethanol (32). 
Inhibitor Studies-For studies using N-ethylmaleimide, NEM was 
dissolved in ethanol, diluted 8-fold with HZO, and added to each 
reaction mixture to a final concentration of 5 mM with ethanol below 
0.5%. After incubation on ice for various times, the NEM was inac- 
tivated by the addition of DTT  to 5 mM. Samples remained on ice 
until the carboxylation assay was begun 10 min later. The zero time 
NEM preincubations had DTT added just prior to  the NEM, whereas 
control incubations contained only ethanol. Each data point repre- 
sents a single assay point. 
To investigate the effect of warfarin upon carboxylase, we made a 
nearly saturated 62.5 mM warfarin solution in ethanol and diluted 
portions of this stock with ethanol to  the appropriate  concentrations 
for the concentration curve. Unless otherwise stated, warfarin was 
added to  the ice-cold reaction mixture as 2% of the final reaction 
volume, prior to  the  start of the carboxylase assay. For the competi- 
tion experiments between warfarin and vitamin KHz, final warfarin 
concentrations were  1.25,  0.63,  0.31, and 0 mM, whereas the vitamin 
KHz curve included concentrations at 14.2, 20, 33, and 100 pM. To 
generate a  time course for warfarin inactivation of carboxylase, sam- 
ples of the reaction mixture, including carboxylase were placed at 
22 "C, and warfarin was added at  various times prior to  the  start of 
the carboxylation reaction. Uninhibited controls included ethanol. 
Each data point  represents  a single assay point in the above warfarin 
experiments. To investigate the irreversibility of warfarin inhibition 
of carboxylase, the carboxylase was preincubated for 30 min with 1 
mM warfarin in 100 p1 of standard reaction solution, lacking only 
FLEEL  and  the vitamin KHz/NaH'COz mixture. The warfarin was 
removed from samples by diluting 11-fold in like buffer minus CHAPS 
and PC, then reconcentrating using a Centricon 30 concentrator 
(Amicon) at 5000 X g for 25 min. After recovery of the centrifuged 
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samples, the volumes were readjusted to 100 p1 with flow-through, 
and each sample had 15 pl of 30 mM FLEEL added. Ten minutes 
later, the carboxylase assay was begun. All samples, including those 
that were not washed, were maintained at  22 "C for the  entire 2-h 
procedure. Uninhibited controls included only ethanol, and both 
washed and unwashed controls were done. The removal of 90% of the 
warfarin was confirmed with radioactive warfarin. To determine if 
vitamin K epoxide or vitamin K1 could protect the carboxylase from 
warfarin inactivation, they were added to samples of prewarmed 
reaction mixture before reaction initiation, whereas warfarin was 
added immediately after. The final  vitamin K epoxide and vitamin 
K1 concentrations were 178 pM, whereas warfarin was 0.75 mM. 
Ethanol from the vitamin K epoxide or vitamin K, and from the 
warfarin comprised 2% of the reaction volume. 
RESULTS 
Carboxylase  Assay-The reaction velocity was linear for at 
least half an hour under  standard  conditions  in which vitamin 
KHz was saturating.  This was also true at  the nonsaturating 
vitamin  KHz  concentrations of 55 pM (Fig. 1) and 22 pM (data 
not shown). Oxidation of the vitamin  KHz  during  extraction 
and analysis prevented quantitation of the actual reaction 
concentration of the reduced form; however, 40% of the 
vitamin  KHz was  recovered using oxygen-free extraction  and 
high performance liquid chromatography techniques,  and this 
proportion was constant for over 1 h. Linearity with respect 
to time was also observed at NaHI4CO3 concentrations from 
0.1-0.6 mM (data  not  shown). Over this range of concentra- 
tions, loss of NaH14C03 as I4CO2  was determined by scintil- 
lation counting to be less than 10%  during  a 30-min assay. 
Even in the absence of DTT,  the carboxylase reaction with 
55 p~ vitamin KHz was linear for at least 30 min. Experiments 
without DTT used hydrosulfite-reduced vitamin KHz. Vita- 
min KHz reduced by either DTT or hydrosulfite gave equiv- 
alent activity when DTT was present in the assay. 
In  this report, the carboxylase activity has generally been 
expressed as  a normalized velocity to prevent confusion aris- 
ing from the variable amounts of carboxylase present in 
different experiments. The normalized velocity is defined as 
mol l4COZ incorporated/s/mol carboxylase and has units of 
s-'. In Fig. 1, the reaction velocity with 222 PM vitamin KH, 
was 0.4 s-' during the linear period of the reaction. The 
carboxylase activity was linearly dependent upon carboxylase 
concentration over the range of concentrations used in these 
experiments  (data  not  shown). 
Carboxylase Stability-Prior to dilution in  the reaction mix- 
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FIG. 1. Time  course of carboxylation reaction. Purified  car- 
boxylase (34 ng) was assayed at 22 "C for the times indicated with 
55.5 pM (0) or 222 p M  (0) vitamin KH2. 
and were unstable at room temperature, with half-times of 
decay of less than 1 h. The stability of a  fraction was related 
to  its CHAPS concentration, and at 4 "C the half-times of 
decay range from 8 to 90 h at approximately 1.2 and 0.6% 
CHAPS, respectively. The decay rate was not  first-order,  as 
the example shown in Fig. 2 demonstrates. One possible 
explanation for this is the presence of two forms of carbox- 
ylase with different first-order decay rates, and the curve  in 
Fig. 2 was generated from a model in which 57% of the 
carboxylase has a half-time of decay of 6  h  and 43% of  69 h. 
Once the carboxylase was diluted in the reaction mixture, 
it was much more stable at room temperature.  This is evident 
in the linearity of the reaction and  in the uninhibited control 
of the warfarin inhibition time course reported below. 
Carboxylase Actiuators-Table I shows the effect of pro- 
FIX19 and  (NH4)$304 upon carboxylase activity in two phos- 
pholipid environments. The effect of phospholipid environ- 
ment on carboxylase activity was further investigated in the 
presence of 0.8 M (NH4)2S04  and 10.2 pM proFIX19. Essen- 
tially maximal activity was observed at CHAPS/PC ratios 
near 1 at CHAPS  concentrations from  0.1 to 0.7%. At 
CHAPS/PC  ratios above 2, activity fell off rapidly, particu- 
larly at high CHAPS  concentrations.  In  contrast, at CHAPS/ 
PC  ratios below  0.6, the activity dropped off more gradually. 
The reducing agent, DTT, is a stimulator of carboxylase 
activity in crude microsomes. When DTT was  removed  from 
the  standard reaction, activity decreased modestly to between 
60 and 75% of stimulated values in reactions using 55 pM 
vitamin KHz. Since the reaction was linear with or without 
100 
0 10  20 30 40  50 60 70
incubation Time (hours) 
FIG. 2. Stability of carboxylase in 1.2% CHAPS at 4 O C .  One 
fraction of carboxylase was incubated at 4 "C for the times indicated, 
prior to assay under standard conditions. 
TABLE I 
Effect of activators on carboxylation 
Purified carboxylase was assayed under standard conditions, except 
that proFIX19, (NH4),S04 and CHAPS/PC were at  the concentra- 
tions indicated. It should be noted that all assays necessarily con- 
tained 0.016% PC, 0.1% CHAPS, and 0.2 p M  proFIX19, included 
with the purified carboxylase. Values are the averages of between 3 
and 5 data points from three experiments. 
Activity as a percentage of 
maximally  stimulated 
0.016% PC/O.l% 0.216% PC/0.3% 
CHAPS  CHAPS 
Activators 
0.2 p M  proFIX19 1.7  24 
0.2 p M  proFIX19 + (NH4)zSOI 23 86 
10.2 p M  proFIX19 2.5 33 
10.2 p~ proFIX19 + (NH4)B04 56 100 
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DTT being present, the stimulation by DTT is unlikely to be 
an artifact of greater vitamin KH2  stability  in the presence of 
DTT. 
Vitamin K Epoxidase and Vitamin K Epoxide Reductase 
Actiuities-As shown in Table 11, essentially equimolar 
amounts of vitamin K epoxide and Gla residue were formed 
in  the presence of near-saturating bicarbonate. No vitamin K 
epoxide reductase activity was evident under the conditions 
used. 
Carboxylase  Kinetics-The presence of 222 p~ vitamin K 
epoxide or vitamin K1 had no effect upon the rate of carbox- 
ylation in assays using 55.5 p M  vitamin KHz. 
In at least three initial rate experiments for each of the 
substrates  FLEEL, vitamin KHz  and NaH14C03, the Km(app), 
or concentration at half-maximal activity, differed from the 
median value by 15% or less. This was true even though the 
purified carboxylase was from different points along the elu- 
tion gradient of three purifications. 
Initial  rate  experiments in which the  FLEEL concentration 
was varied displayed non-Michaelis-Menten kinetics at high 
substrate  concentrations (Fig. 3A). The decreased activity at 
high substrate  concentrations was consistent with substrate 
inhibition. This nonideality makes determining Km(app) and 
Vmax(app) roblematic (33); however, the FLEEL  concentration 
at half-maximal velocity  was determined to be 1.0 mM. Alter- 
natively, an observed Km(epp) may be estimated from the linear 
portion of the Lineweaver-Burk plot (Fig. 3B), yielding a 
value of 1.6 mM. 
Reactions with varied vitamin KH2 concentration also gave 
non-Michaelis-Menten kinetics, although in some plots the 
effect is not obvious (Fig. 4A). The Eadie-Hofstee plot in Fig. 
4 8  shows clearly that activity at high vitamin KHz concen- 
trations was below that expected for a reaction behaving 
according to Michaelis-Menten kinetics. Concentrations of 
vitamin KHz up to 444 p~ gave no additional activity. The 
vitamin KHz  concentration at half-maximal velocity  was 36 
PM in this experiment. When ethanolic stocks of hydrosulfite- 
TABLE I1 
Comparison of “C02 incorporation  into Gla and  vitamin K epoxide 
formation 
As described under  “Materials and Methods,” purified carboxylase 
was assayed for Gla and vitamin K epoxide formation in the presence 
of nearly saturating bicarbonate. 
Time Gla formed Vitamin K epoxide formed 
nin pmok pmole 
30 68 60 
60 110 140 
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reduced vitamin KH2 were used, the same pattern of prema- 
ture  saturation was  observed. Unfortunately, use of ethanolic 
vitamin KH2 stocks resulted in a precipitate if the stock 
concentration was more than 6.25 mg/ml (13.9 mM). The 
precipitate was visible and resulted in lower activity that was 
only partially reversed during  a  time course of the reaction or 
by preincubation at 22 “C. The results for concentrations 
below 225 p~ vitamin KH2 were apparently unaffected, as 
sufficiently dilute stocks yielded concentrations higher than 
225 p~ at ethanol  concentrations (<2%) that did not affect 
activity. 
The plot of initial  rate uersus NaH14C03 concentration in 
Fig. 5 and  the corresponding Eadie-Hofstee transformation 
(inset), display the Michaelis-Menten kinetics of the carbox- 
ylation reaction with respect to  this substrate. The estimated 
Km(app) is 0.30 mM. 
No studies of the oxygen dependence of carboxylation were 
done, as  the presence of high salt  and DTT made the dissolved 
oxygen concentration indeterminable. However, it was found 
that  the carboxylation rate under normal atmosphere (21%, 
02) was 80 +- 4% of that observed under an oxygen atmos- 
phere. To confirm the dependence of the carboxylase upon 
oxygen, we performed the reaction under N2 atmosphere and 
included a glucose-glucose  oxygenase system (32) to remove 
any remaining oxygen. Catalase was also included to prevent 
any possibility of H20z buildup that could artifactually lower 
activity. Under these conditions, more than 99% of carbox- 
ylation activity was lost. 
In an effort to determine the maximal activity of the 
carboxylase, we repeated the NaH14C03 initial rate experi- 
ments under an oxygen atmosphere with 7.2 mM FLEEL  and 
222 PM vitamin KH2. Under these conditions we obtained a 
Vmar(app) of 1.0 s-’. The presence of an oxygen atmosphere did 
not affect reaction linearity during the 15-min assays used in 
this experiment. 
Carboxylase Inhibitors-When preincubated with the 
sulfhydryl reactive agent,  NEM, the carboxylase was inhibited 
in an irreversible, time-dependent  manner (Fig. 6). The decay 
rate was not pseudo first-order as might be expected for a 
homogeneous population of carboxylases being inhibited at a 
single site. 
Warfarin  inhibited carboxylase in a  concentration-depend- 
ent manner (Fig. 7A). To investigate the mechanism of the 
inhibitory effect of warfarin on carboxylase, we did initial 
rate  studies at several concentrations of vitamin KHz with 0, 
0.31, 0.63, and 1.25 mM warfarin (data not shown). Surpris- 
ingly for an inhibitor of all vitamin K-dependent enzymes, 
we observed perfect non-competitive inhibition. Although 
-1.0 -0.5 0.0 0.5 1.0 1.5  2.0 2.5 3.0 3.5 
l/[FLEEL] (l /mM) 
FIG. 3. Dependence of carboxylation velocity upon FLEEL concentration. Purified carboxylase (62 ng) was assayed for 15 min 
with varying concentrations of FLEEL. Both A and  the Lineweaver-Burk plot of these data in B show inhibition of activity at high substrate 
concentrations. The linear regression in B used only the lowest  five concentration points. 
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FIG. 4. Dependence of carboxylation velocity upon vitamin 
KH2 concentration. Purified  carboxylase (112 ng) was  assayed for 
30 min with  varied  concentrations of vitamin  KHp. The  initial  rate 
data are presented in A with the corresponding Lineweaver-Burk 
transformation as an inset. The  corresponding  Eadie-Hofstee plot in 
B indicates  non-Michaelis-Menten  behavior.  Linear  regressions ex- 
cluded the  top  four  concentrations. 
noncompetitive inhibition seems unlikely, it is very possible 
that warfarin is acting  as an irreversible inhibitor, resulting 
in  a common artifact that yields data  that appear noncom- 
petitive (34). Following a 30-min preincubation with 1 mM 
warfarin, removal of 90% of the warfarin by washing (details 
under "Materials and Methods") resulted in the recovery of 
none of the inhibited activity. In this experiment, washed 
uninhibited controls retained 90% of the activity observed in 
uninhibited  controls that were not washed. To demonstrate  a 
time dependence to warfarin inactivation of carboxylase, we 
preincubated the carboxylase with 1.25 mM warfarin for var- 
ious times prior to  the carboxylation assay (Fig. 7 B ) .  Because 
most inactivation occurred even in the absence of a warfarin 
preincubation, only a modest time-dependent effect was ob- 
served. Like NEM, the decay rate observed for warfarin 
inactivation of carboxylase was not pseudo first-order. Nei- 
ther vitamin K epoxide or vitamin K1 had any effect on 
warfarin inactivation of carboxylase. During these experi- 
ments it was noticed that 4% ethanol  inhibited carboxylase 
from 30 to 50%, whereas ethanol at 2% or less had no 
inhibitory effect. The uninhibited  control in Fig. 7B demon- 
strates  the relative stability of carboxylase under conditions 
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FIG. 5. Dependence of carboxylation velocity upon Na- 
H1'C03 concentration. Purified carboxylase (112 ng) was assayed 
for 30 min with varied concentrations of NaH"C03. Initial  rate  data 
in Fig. 5 and  the  Eadie-Hofstee  transformation of this  data (inset), 
show that carboxylase displays Michaelis-Menten behavior with re- 
spect  to this  substrate. 
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FIG. 6. NEM inactivation of carboxylase. Purified  carboxylase 
(82 ng) was preincubated in the presence (0) or absence (0) of 5 mM 
NEM on ice for the times  indicated.  The  NEM was then  inactivated 
with DTT, and the samples assayed 15 min. Details are included 
under  "Materials  and  Methods." 
DISCUSSION 
The initial  linearity of the carboxylation reaction indicated 
that changes in conditions such as carboxylase inactivation, 
loss of NaH14C03, and oxidation of vitamin KHz were not 
large enough to affect linearity. Enzyme inactivation and 
NaH14C0, loss were confirmed to be 10% or less in a half- 
hour reaction. Even a 10% loss would result in a smaller 
percent decrease in activity for the entire reaction period and 
would probably not be apparent. Similarly, during the first 
hour of reaction no evidence of time-dependent oxidation of 
vitamin KHz was observed, as  the proportion of reduced and 
oxidized vitamin  K remained constant. The apparent stability 
of vitamin KHz under reaction conditions is consistent with 
the reaction linearity observed at vitamin KHz concentrations 
as low as 22 PM. This  contrasts with the situation reported in 
crude microsomal systems lacking DTT, where oxidation of 
vitamin  KHz is reported to be  more rapid (35, 36). Although 
the reason for this difference is not  apparent, the composition 
of the purified carboxylase system is significantly different 
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FIG. 7. Warfarin inactivation  of  carboxylase. In the experi- 
ment shown in A, 62  ng of carboxylase was assayed for 30 min in the 
presence of varying amounts of warfarin.  For the experiment  in B,  
the carboxylase was preincubated at 22 “C with (0) or without (0) 
1.25 mM warfarin for the times  indicated,  prior  to  assay. Assay was 
for 10 min, and  62 ng of carboxylase was used. 
from the crude microsomal systems. 
Phospholipid environment and the activators proFIX19 
and  (NH&S04 clearly affect carboxylase activity in an inter- 
dependent manner. Depending on conditions, (NH4)S04 
stimulation ranged from 3.6- to 13-fold, whereas increasing 
propeptide concentration from 0.2 to 10.2 pM stimulated from 
1.13- to 2.5-fold. The importance of the phospholipid environ- 
ment to active carboxylase was seen in  the decreased activity 
observed at CHAPS/PC ratios below 0.6 and above 2. A 
CHAPS/PC ratio of 2 is near the point at which mixed 
micelles and mixed  vesicles are  both  present. The fact that 
high CHAPS  concentrations  inactivate the carboxylase may 
be linked to  the conversion of carboxylase-containing vesicles 
into micelles. 
In crude soluble microsomes, the presence of saturating 
amounts of bicarbonate results in the production of equimolar 
amounts of Gla and vitamin K epoxide (26). The production 
of equimolar amounts of Gla and epoxide in our purified 
system, when combined with the homology to a known epox- 
idase observed in  the amino acid sequence of the carboxylase 
(16), is strong evidence that  the vitamin  K epoxidase is part 
of the carboxylase. 
The kinetic behavior of the purified carboxylase was similar 
to  that reported for the carboxylase activity present in solu- 
bilized microsomal preparations; however, qualitative com- 
parison is not possible as conditions and  cosubstrate concen- 
trations have varied. The inability of vitamin K epoxide and 
vitamin  KI to compete with vitamin KHz probably indicates 
the vitamin KHz-binding site is not available to the other 
forms. However, our lack of knowledge about how the various 
forms of vitamin K1 partition between mixed  micelles,  mixed 
vesicles, and aqueous environments or even in which environ- 
ment  and with what  orientation  vitamin KHz is active, sug- 
gests caution  in making this  interpretation. 
Values o f  Km(epp) reported in the literature for the  substrate 
FLEEL have been estimated from initial  rate  studies done at 
low substrate  concentrations where substrate inhibition may 
not have become evident. This may be the reason that  the 
apparent substrate inhibition has been reported only once 
(37). Although substrate  inhibition-like behavior may or may 
not have occurred in these  earlier  reports, it is clearly present 
in our  data  and makes use of Km(app) inappropriate because 
the observed Km(app) has probably been shifted from the actual 
Km(app) by the inhibitory effect (33). For these reasons, the 
more general term, concentration at half-maximal activity, 
should be used, and in our experiments  it was estimated to be 
1 mM for FLEEL. In studies done on solubilized microsomes, 
the  first reported Km(app) for FLEEL is 4 mM (9); however, a 
more recent study shows that Km(app) may range from  1.6 to 
14 mM, depending upon cosubstrate  concentrations (38). Un- 
der conditions very similar to ours, in which both propeptide 
and (NH4)&304 are  present in the reaction, two groups esti- 
mate Km(app) of 2.2 and 4.6 mM (11, 21). Given the wide 
variation in reported values, our estimate of the concentration 
at half-maximal velocity as 1 mM is in reasonable agreement. 
This is particularly true since the obserued Km(app) estimated 
from the portion of the initial rate  data  that show no obvious 
inhibition is 1.6 mM. It should be noted that while propeptide 
lowers the K,,, of peptide substrates (11, 17), this effect is 
apparently blocked in  the presence of (NH&S04 in bovine 
microsomes (17). Presently it is not known if substrate  inhi- 
bition is a  property of peptide substrates or if it also influences 
native  protein carboxylation. 
Initial rate experiments with vitamin KHz also did not 
display Michaelis-Menten kinetics at high substrate concen- 
tration; however, half-maximal activity was observed at 30- 
40 p ~ ,  which is within the range of values of  10-100 p~ found 
in  studies done on crude solubilized microsomes ( 5 ,  28). An 
explanation for the reaction reaching Vmax at a vitamin KHz 
concentration well below that predicted from behavior at 
lower concentrations is beyond the scope of this paper, given 
the unknown influence of vitamin KHz partitioning men- 
tioned earlier. To eliminate the possibility that solvent or 
lipid present in the vitamin K1 from the manufacturer was 
inhibiting the carboxylase at high vitamin KHz concentra- 
tions, we used hydrosulfite-reduced vitamin KHz to repeat 
the initial  rate  study  and observed the same premature  satu- 
ration effect. Few studies have been done at high enough 
vitamin KHz concentration and with sufficient accuracy to 
show this early saturation effect. However, in the most thor- 
ough kinetic  study of the carboxylase activity done to date 
(38), some experiments  appear to show early saturation.  In 
“Exp. 1/Fig. 1” of that study, maximal activity has been 
reached at 80 p~ despite estimated Km(app) concentrations of 
between 41 and 51 p ~ .  Another complication results from our 
inability to demonstrate that more than 40% of the vitamin 
K  remains reduced in  the reaction. Thus we cannot eliminate 
the possibility that  the actual  vitamin  KHz  concentration is 
somewhat lower than  the added vitamin  KHz concentration. 
However, even when  fully reduced stocks of vitamin KHz are 
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analyzed, recovery of the reduced form is only 60-70%. For 
this reason, we believe much of the low recovery from ex- 
tracted reactions is due to oxidation during analysis. Since 
this factor could not be quantitated  or eliminated, we have 
presented our data without correction for the low vitamin 
KH2 recovery, even though this  has probably resulted in a 
slight overestimation of the concentration at half-maximal 
activity. Note that  the carboxylation reaction with endoge- 
nous substrates requires less vitamin KHz. The vitamin K1 
concentration in mammalian liver is about 0.1 pM (39),  and 
earlier systems using endogenous substrate  report lower vi- 
tamin  KH2 requirements (4, 5)  than observed in  our system. 
Recently, a study using propeptide-containing  substrates  has 
found a much lower K,,, for vitamin KHz (1 pM) in a soluble 
microsomal system (40). We have confirmed this with the 
substrate  FIXQ/S  (27) in our purified system.' 
The Michaelis-Menten kinetics observed with NaH14C03 
allows estimation of a of  0.25-0.3  mM, in agreement 
with the low end (38,41,42) of reported values, which range 
from 0.2 to 2 mM (6).  The presence of endogenous NaHC03 
is a serious problem in determining the K,,, for NaH14C03, 
and  estimates yielding higher values either do not appear to 
have adjusted K,,, in response to  the presence of endogenous 
NaHC03 or used a nonreproducible quantitation technique 
(6) for measuring NaHC03. However, somewhat different 
systems are used, and K,,,(app) may indeed vary. As pointed  out 
by Uotila (38), the actual Km(app) will  be the observed 
for NaH14C03 minus the endogenous NaHC03  concentration. 
In our assays, deionized H 2 0  was used for all solutions, and 
this water contained less than 5 p~ NaHC03  as estimated by 
acidification and IR spectroscopy. However, when a large 
volume of reaction mixture was prepared from stock solutions 
including carboxylase and lacking only FLEEL and Na- 
H14C03, the  NaHC03 concentration  had risen to 40 p ~ .  The
small volumes used in the reaction would have somewhat 
higher endogenous levels, as  they were exposed to atmospheric 
C02 during  set  up  and reaction. Fortunately, this must be a 
small effect, as the reaction is linear even at low NaHI4CO3 
concentrations.  Elimination of this variable requires precise 
control and measurement of endogenous NaHC03 under re- 
action conditions and is not  presently possible for us. For this 
reason, and because the correction is not too large, we have 
presented our results without correction. 
Oxygen  was clearly required for carboxylation, as deoxygen- 
ation with a glucose-glucose  oxygenase system under  a  nitro- 
gen atmosphere eliminated more than 99% of carboxylase 
activity. Performing reactions under an oxygen atmosphere, 
which should result in nearly a &fold increase in dissolved 
oxygen concentration, increased activity only 20%. This be- 
havior suggests the dissolved  oxygen concentration  in equilib- 
rium with the atmosphere is above K,,,, as previously reported 
(6, 41) and  that  the dissolved oxygen concentration under an 
oxygen atmosphere is well above K,. In order to determine 
V, of carboxylase, it is necessary to have all four substrates 
present at saturating concentrations or at concentrations 
capable of generating maximal activity. Under an oxygen 
atmosphere with vitamin  KH2 (222 p ~ )  and FLEEL (7.6 mM) 
at concentrations generating maximal activity, initial rate 
experiments with varying NaH14C03 concentration produce 
an estimated Vmax(app) of 1.0 s-'. Under these conditions, this 
Vmlu(app) should be  close to  the V,. of the enzyme, and since 
kat = V,,/[enzyme~,wl, this normalized Vmax approximates 
the kcat for the carboxylase in this system. 
The sulfhydryl-reactive agent,  NEM,  inhibits carboxylase 
presumably by covalent association to one, or possibly two, 
D. P. Morris, unpublished observation. 
free sulfhydryl groups probably near, or part of, the active 
site of this  protein. We found that NEM inhibited purified 
carboxylase to  the same extent  as  it inhibits the carboxylase 
activity in crude soluble microsomes (23). It has been sug- 
gested that a  free sulfhydryl, protected from NEM inactiva- 
tion by vitamin KHz, is involved in the epoxidase activity, 
whereas modification of a second sulfhydryl, not protected by 
vitamin KH2, blocks only carboxylation activity. Such a com- 
plex inhibitory mechanism is consistent with the nonpseudo 
first-order inactivation rate observed in our study. Identifi- 
cation of the responsible sulfhydryl(s) in purified carboxylase 
using radioactive NEM should clarify the mechanism of in- 
activation. 
In uiuo, the sites of action of the vitamin K antagonist 
warfarin are almost certainly the DTT-dependent, vitamin 
K, and vitamin K epoxide reductase activities (24, 43, 44). 
Inactivation of the reductases has been shown to be irrevers- 
ible in vitro at micromolar warfarin concentrations  (43). At  
higher concentrations, warfarin apparently  inhibits  all of the 
known enzymes involved in the vitamin K cycle (24). The 
carboxylase activity present in crude soluble microsomes is 
reportedly inhibited by warfarin with an IC5o of  2-3 mM (24). 
Purified carboxylase was also inhibited by warfarin, appar- 
ently by an irreversible mechanism and at somewhat lower 
concentration than in the crude preparations. Although in- 
hibition of the carboxylase occurred at a 1000-fold higher 
concentration than  the physiologically relevant reductase in- 
hibition, the fact that all known vitamin K-dependent  pro- 
teins  are  inhibited by warfarin (24) suggests that  the inhibi- 
tion is mechanism-based. Because the inhibition appears to 
be irreversible, the significance of a lower inhibitory concen- 
tration is uncertain. It is somewhat surprising that we did not 
observe vitamin K protection (any form) of the carboxylase 
from warfarin inactivation. The inability of vitamin KHz  to 
protect the carboxylase from warfarin inactivation, the  non- 
first-order decay of the carboxylase, and  the nonpseudo first- 
order decays observed for warfarin and NEM inactivation of 
the carboxylase are all consistent with the carboxylase having 
two functionally different conformations. 
Recently, Berkner et al. (45) reported purification of the 
carboxylase to a somewhat higher specific activity than we 
previously reported (15). No evidence is presented that  this 
identical molecular weight protein is different from the vita- 
min K-dependent carboxylase we had previously purified. 
Furthermore, the major steps of both purifications are essen- 
tially the same (propeptide affinity/cation exchange). The 
specific activity in their  recent  report, which  was determined 
under different assay conditions, is only 6-fold higher than 
observed in our preparations when differences in protein 
quantitation technique are accounted for (bovine serum al- 
bumin, used as  a  protein  standard by Berkner et al., binds 2.5 
times more Coomassie Blue than IgG, which we used (46)). 
Six-fold is not  a large difference, as  both protein quantitation 
by  gel scanning  and the carboxylase assay are  prone to vari- 
ability. For example, we find that boiling the carboxylase in 
sodium dodecyl sulfate containing sample buffer will cause an 
insoluble precipitate that does not  enter  the gel, resulting in 
an underestimation of protein  and an overestimation of spe- 
cific activity. Because identification of the carboxylase as  the 
major band in our purifications is so strongly supported (15, 
16),  and because all of the carboxylase activity present in our 
starting microsomes was  recovered in either the retained or 
discarded materials,' we are confident our purified carboxyl- 
ase is correctly identified and fully active. However, it is 
possible that activity may be somewhat higher under alter- 
native reaction conditions. 
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Under defined assay conditions, purified vitamin K-de- 
pendent carboxylase demonstrates very similar  characteristics 
to the carboxylase activity seen in solubilized microsomal 
preparations. Carboxylase, from  various  points  along  the  elu- 
tion gradient of three purifications, appears to exhibit a 
consistent set of characteristics. Our in vitro system using 
purified carboxylase will allow detailed  investigation of the 
carboxylation  mechanism  and  the role of the  propeptide  in 
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